Insight

Promising results from a Phase 1 clinical trial – Chordoma Foundation

Photo taken from Chordoma Foundation/X

Jul 13, 2024, 11:09

Promising results from a Phase 1 clinical trial – Chordoma Foundation

Chordoma Foundation made the following post on X:

“Promising results have emerged from a Phase 1 clinical trial testing a new drug from Erasca called ERAS-601 alone & in combo w/ cetuximab: Nearly all of the 13 chordoma patients enrolled had some tumor shrinkage. More.”

Source: Chordoma Foundation/X

cancer Cancer research cetuximab combination therapy Chordoma Foundation chordoma treatment clinical trial results ERAS-601 Erasca OncoDaily Oncology Oncology News Phase 1 clinical trial Precision Medicine rare cancer treatment tumor shrinkage

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage